ourlyard glp 1 six in one GLP-1 Review – LEGIT OR SCAM PRODUCT? GLP-ONE + Receptor Activator
Description
Among the marketed large molecule injectable GLP-1 agonists, semaglutide, apart from weight-loss, is being studied for kidney disease and tirzepatide (a dual GLP-1 and GIP receptor agonist) is being evaluated for sleep apnea in Ph 3 clinical trials
Lumin Research, research use only.
Methods Retrospective study utilizing data from a federated research network (TriNetX)
Learn to support clients on medications like Ozempic with expert guidance on exercise, nutrition, and blood labs
Conclusions GLP-1RAs had a neutral effect on the composite cardiovascular outcomes but reduced composite kidney events in the patients with advanced DKD compared with DPP-4is.
Join our exclusive pre-launch waitlist today.
